Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 06:26 am Sale |
2021-12-31 | 13G | Aura Biosciences, Inc. AURA |
Citadel Advisors LLC | 2,315,102 7.900% |
-2,656 (-0.11%) |
Filing History |
| 2022-02-11 5:59 pm Purchase |
2021-12-31 | 13G | Aura Biosciences, Inc. AURA |
Advent Life Sciences LLP | 2,023,857 6.900% |
2,023,857 (New Position) |
Filing History |
| 2022-02-10 4:35 pm Purchase |
2021-12-31 | 13G | Aura Biosciences, Inc. AURA |
Arix Bioscience plc | 1,600,076 29.210% |
91,593 (+6.07%) |
Filing History |
| 2022-01-26 4:06 pm Purchase |
2021-12-31 | 13G | Aura Biosciences, Inc. AURA |
Lundbeckfond Invest A/S | 2,017,652 6.900% |
2,017,652 (New Position) |
Filing History |
| 2021-11-12 4:30 pm Purchase |
2021-11-02 | 13G | Aura Biosciences, Inc. AURA |
Chiesi Ventures Inc. | 1,625,071 5.800% |
1,625,071 (New Position) |
Filing History |
| 2021-11-12 4:07 pm Purchase |
2021-11-02 | 13G | Aura Biosciences, Inc. AURA |
Citadel Advisors LLC | 2,317,758 8.200% |
2,317,758 (New Position) |
Filing History |
| 2021-11-10 3:21 pm Purchase |
2021-11-02 | 13D | Aura Biosciences, Inc. AURA |
Medicxi Growth I LP | 3,039,892 10.700% |
3,039,892 (New Position) |
Filing History |
| 2021-11-10 2:33 pm Purchase |
2021-11-02 | 13G | Aura Biosciences, Inc. AURA |
Arix Bioscience plc | 1,508,483 5.310% |
1,508,483 (New Position) |
Filing History |
| 2021-11-04 4:58 pm Purchase |
2021-11-02 | 13D | Aura Biosciences, Inc. AURA |
Matrix Capital Management Company, LP | 4,112,870 14.480% |
4,112,870 (New Position) |
Filing History |